Allergen has acquired Chase Pharmaceuticals Corporation from New Rhein Healthcare Investors for a purchase consideration of $125m.
Pursuant to the agreement, Chase Pharma will be merged with a subsidiary of Allergan, and Allergan will be responsible to pay additional potential regulatory and sales milestone-based payments to Chase Pharma.
Go deeper with GlobalData
The acquisition will allow the acquirer to further expand its CNS research and development (R&D) pipeline.
Primex Pharmaceuticals has acquired Giovanni Ogna& Figli with the aim of expanding its product portfolio of dental surgery products.
Pursuant to the agreement, Primex will merge all the former OGNA companies into the original company, Giovanni Ogna et Figli.
See Also:
Chiesi Farmaceutici plans to acquire Atopix Therapeutics by purchasing all its outstanding shares for a purchase consideration of $79.4m.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe acquisition will enable Chiesi Framaceutici to expand its product portfolio for respiratory and eosinophilic airways diseases.
